Skip to main content

Table 4 Incremental cost-effectiveness ratio (ICER)

From: Cost-effectiveness analysis of nephroprotection programs for patients with type 2 diabetes mellitus in insurers in Colombia

Interventions

Total Cost ($USD 2023)

Effect (controlled patients)

CER [C/E]

ICER [ΔC/ΔE]

Without Nephroprotection

$ 389,992.00

277.69

$ 1,404

 

With Nephroprotection

$ 386,448.20

283.20

$ 1,365

Dominant